comparemela.com

Latest Breaking News On - Booster molecule - Page 1 : comparemela.com

Poseida Therapeutics Announces Virtual 2024 Annual Meeting Of Stockholders

SAN DIEGO, June 3, 2024 /PRNewswire/ Poseida Therapeutics, Inc. (Nasdaq: PSTX ), a clinical-stage allogeneic cell therapy and genetic medi

Poseida therapeutics incAnnual meetingPoseida therapeuticsSpecific gene editing systemBooster molecule

Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology

- Leverages Poseida s proprietary allogeneic CAR-T platform to develop innovative convertibleCAR® programs targeting solid tumors - TOKYO and SAN DIEGO, May 1, 2024 /PRNewswire/ Astellas.

Xyphos biosciencesAstellas pharmaKristin yaremaNaoki okamuraAdam pearsonAstellas companyPoseida therapeutics incExchange commissionXyphos biosciences incAreas of interest astellas pharma incAstellas pharma incPoseida therapeuticsChimeric antigen receptorChief strategy officerPrimary focusFocus area approach

Poseida Therapeutics Presents New Phase 1 Data at AACR 2024 Supporting Potential of P-BCMA-ALLO1 Allogeneic CAR-T Therapy to Benefit Broad Range of Patients with Multiple Myeloma

/PRNewswire/ Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with.

San diegoUnited statesSyed rizviRajesh belaniBhagirathbhai dholariaPoseida therapeutics incVanderbilt ingram cancer centerDrug administrationPrnewswire poseida therapeutics incClinical developmentAmerican association for cancer researchAmerican associationCancer researchAnnual meetingAssociate professorChief medical officer

Poseida Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, April 1, 2024 /PRNewswire/ Poseida Therapeutics, Inc. , a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases,.

Syed rizviCompensation committeePoseida therapeutics incPoseida therapeuticsChief medicalNasdaq listing ruleSite specific gene editing systemBooster molecule

Poseida Therapeutics Appoints Syed Rizvi, M D , as Chief Medical Officer

Poseida Therapeutics Appoints Syed Rizvi, M D , as Chief Medical Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesKristin yaremaSyed rizviAmerican society for transplantationVincent comprehensive cancer centerGenta incExchange commissionPoseida therapeutics incAmerican society of clinical oncologyAmerican society of hematologyEuropean hematology associationDow medical collegePoseida therapeuticsChief medical officerChief executive officer

vimarsana © 2020. All Rights Reserved.